Porta E A, Monserrat A J, Berra A, Rubio M C
Dept. Pathology, Sch. Med., Univ. Hawaii, Honolulu.
Adv Exp Med Biol. 1989;266:169-88; discussion 189-90. doi: 10.1007/978-1-4899-5339-1_13.
Previous studies in young normal rats have shown that intracerebral administration of the proteinase inhibitor, leupeptin, caused a rapid accumulation of lipofuscin-like pigment in lysosomes of brain cells (Ivy et al., 1984a). On the other hand, we have recently found that the administration of lovastatin, an inhibitor of HMG-CoA reductase, reduced the ceroid-like pigment and dolichol contents in the crushed epididymal fat pad of rats (Porta et al., 1988). In order to study now the possible modulating effects of these enzyme inhibitors on ceroidogenesis associated with vitamin E deficiency, two main groups of weanling Wistar female rats were respectively fed ad libitum a vitamin E-deficient basal diet, or the same diet supplemented with 16 mg% of dl-alpha-tocopherol acetate. The vitamin E-deficient and -supplemented rats were further subdivided and received for 8 weeks their diets alone or with 2, 1, or 0.5 g of lovastatin/kg of diet. Other subgroups were treated with constant peritoneal infusion of 0.5 mg/day of leupeptin by means of osmotic minipumps (Alzet 2002) consecutively implanted at days 15, 30, and 45. Lovastatin treatment to vitamin E-deficient rats was associated with dose-dependent toxicity, resulting in 100%, 75%, and 50% mortality at concentrations of 2, 1, and 0.5 g/kg diet, respectively. This mortality was mainly due to extensive hepatic necrosis. Food intake and growth rates were reduced, while the relative weights of liver, kidneys, spleen, heart and brain, as well as the serum levels of GPT and GOT were significantly increased over the values of the untreated vitamin E-deficient control rats. The volumetric densities of ceroid pigment and the dolichol contents in liver and kidneys were not significantly modified. Lovastatin toxicity was partially prevented by vitamin E supplementation. However, in these supplemented rats, lovastatin treatment did not modify the volumetric densities of hepatic and renal ceroid, although the contents of hepatic and renal dolichol were significantly increased. No correlations could be found between levels of hepatic or renal ceroid and total dolichol content in vitamin E-deficient and supplemented rats. Leupeptin treatment to vitamin E-deficient rats only slightly reduced food intake and growth rates, and did not significantly modify the relative organ weights or the serum levels of cholesterol, GOT and GPT. Although in both vitamin E-deficient and -supplemented rats the leupeptin treatment consistently showed a tendency to increase the volumetric densities of hepatic and renal ceroid pigment, the differences with the control untreated rats were not statistically significant.(ABSTRACT TRUNCATED AT 400 WORDS)
以往对年轻正常大鼠的研究表明,脑内注射蛋白酶抑制剂亮抑酶肽会导致脑细胞溶酶体中脂褐素样色素迅速积累(艾维等人,1984年a)。另一方面,我们最近发现,给予HMG-CoA还原酶抑制剂洛伐他汀可降低大鼠附睾脂肪垫匀浆中类蜡样色素和多萜醇含量(波尔塔等人,1988年)。为了研究这些酶抑制剂对与维生素E缺乏相关的类蜡样质生成的可能调节作用,将两组主要的断乳Wistar雌性大鼠分别随意喂食维生素E缺乏的基础日粮,或添加16mg%dl-α-生育酚醋酸酯的相同日粮。维生素E缺乏和补充的大鼠进一步细分,分别单独或与每千克日粮含2g、1g或0.5g洛伐他汀一起接受8周的日粮。其他亚组通过在第15天、30天和45天连续植入的渗透微型泵(Alzet 2002)以每天0.5mg的剂量持续腹膜内输注亮抑酶肽进行治疗。对维生素E缺乏的大鼠进行洛伐他汀治疗会产生剂量依赖性毒性,在日粮浓度为2g/kg、1g/kg和0.5g/kg时,死亡率分别为100%、75%和50%。这种死亡率主要是由于广泛的肝坏死。食物摄入量和生长速率降低,而肝脏、肾脏、脾脏、心脏和大脑的相对重量以及血清谷丙转氨酶(GPT)和谷草转氨酶(GOT)水平比未治疗的维生素E缺乏对照大鼠的值显著升高。肝脏和肾脏中类蜡样色素的体积密度和多萜醇含量没有明显改变。补充维生素E可部分预防洛伐他汀的毒性。然而,在这些补充维生素E的大鼠中,洛伐他汀治疗并未改变肝脏和肾脏类蜡样质的体积密度,尽管肝脏和肾脏多萜醇的含量显著增加。在维生素E缺乏和补充的大鼠中,未发现肝脏或肾脏类蜡样质水平与总多萜醇含量之间存在相关性。对维生素E缺乏的大鼠进行亮抑酶肽治疗仅轻微降低了食物摄入量和生长速率,并未显著改变相对器官重量或胆固醇、GOT和GPT的血清水平。尽管在维生素E缺乏和补充的大鼠中,亮抑酶肽治疗始终显示出增加肝脏和肾脏类蜡样色素体积密度的趋势,但与未治疗的对照大鼠相比,差异无统计学意义。(摘要截取自400字)